Share of Piramal Pharma Ltd is currently trading at around Rs.157/- Existing as well as Prospective Investors are asking for Piramal Pharma Share Price Targets for 2024,2025,2030,2035 & 2040. In this article, we will discuss about the business prospects and financial performance of the Company and based on our discussion and analysis will tell you the Piramal Pharma Share Price Target from 2024 to 2040.
Discussion & Analysis of Business & Financial performance with future business prospects of Piramal Pharma Ltd:
Piramal Pharma Ltd. (PPL) has demonstrated robust business performance in FY2024, with significant growth in key financial metrics. The company’s consolidated revenue from operations increased by 15% year-on-year (YoY), reaching INR 8,171 crore. This growth was driven primarily by the Contract Development and Manufacturing Organization (CDMO) segment, which saw a 19% YoY revenue increase. The India Consumer Healthcare (ICH) segment also contributed to the positive performance with a 13% YoY increase in revenue.
The company’s earnings before interest, taxes, depreciation, and amortization (EBITDA) grew by 61% YoY to INR 1,372 crore, with an improved EBITDA margin of 17% compared to 12% in the previous year. This was attributed to operational efficiencies, cost optimization, and strategic initiatives aimed at enhancing productivity.Additionally, the net profit after tax (before exceptional items) more than doubled, reaching INR 132 crore in Q4 FY2024, compared to INR 50 crore in Q4 FY2023
Piramal Pharma’s strategic focus on expanding its CDMO business and optimizing its operational processes has positioned it well for future growth. The company has also made significant strides in reducing its net debt, which decreased from INR 4,781 crore at the beginning of the financial year to INR 3,932 crore by the end of FY2024. This improvement in financial health provides a solid foundation for future investments and expansion.
Looking ahead, Piramal Pharma’s prospects appear promising. The company plans to continue leveraging its strong capabilities in the CDMO segment, which is expected to benefit from increasing global demand for outsourced pharmaceutical manufacturing services. Furthermore, the ongoing development of new products and the expansion of its product portfolio in the ICH segment are anticipated to drive sustained revenue growth. The company’s commitment to sustainability and reducing greenhouse gas emissions also aligns with global trends towards more environmentally responsible business practices, which could enhance its reputation and market position.
Overall, Piramal Pharma Ltd. is well-positioned to capitalize on its strengths and market opportunities, with a strategic focus on growth, innovation, and sustainability.
Share Price Targets:
Piramal Pharma Share Price Target 2024
Based on the above discussion and analysis, the share price of Piramal Pharma is likely to touch the level of around Rs.175-180 in 2024
Piramal Pharma Share Price Target 2025
Based on the above discussion and analysis, the share price of Piramal Pharma is likely to touch the level of around Rs.200-225 in 2025
Piramal Pharma Share Price Target 2030
Based on the above discussion and analysis, the share price of Piramal Pharma is likely to touch the level of around Rs.350-375 in 2030
Piramal Pharma Price Target 2035
Based on the above discussion and analysis, the share price of Piramal Pharma is likely to touch the level of around Rs.565-580 in 2035
Piramal Pharma Price Target 2040
Based on the above discussion and analysis, the share price of Piramal Pharma is likely to touch the level of around Rs.900-1000 in 2040
Disclaimer: Investment in Capital Market/Share Prices are subject to market fluctuations and are dependent on several factors. These predictions are based on the current market conditions and the future market expectations. Investors are advised to take into consideration all these factors before making any investment in Capital Market. This article should not be treated as Investment advisory and is for general Guidance & Educational purpose only. We keep revising our share price targets based on the latest information available with us. Please keep visiting our website regularly to keep yourself updated. MoneyInsight does not offer investment advice and does not encourage any action based on its content.
Read Also:
How to make maximum profit with minimum investment from the Stock Market ? – MoneyInsight
Also Read :
How to make money from share market? (indiatimes.com)
Visit our Website regularly for more such Educational Research Articles:
MoneyInsight – We Provide Insight to Your Money
